Chemomab Therapeutics Ltd. Professional Fees
Chemomab Therapeutics Ltd. (CMMB) reported Professional Fees of $1.24 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-03-23
- Chemomab Therapeutics Ltd. professional fees for fiscal 2020 was $828.00K.
| Period end | Professional Fees 6 month | Professional Fees 12 month |
|---|---|---|
| 2025-12-31 | $1.24M 20-F · filed 2026-03-23 | |
| 2025-06-30 | $653.00K 6-K · filed 2025-08-14 | |
| 2024-12-31 | $1.11M 20-F · filed 2026-03-23 | |
| 2024-06-30 | $557.00K 6-K · filed 2025-08-14 | |
| 2023-12-31 | $2.14M 20-F · filed 2026-03-23 | |
| 2022-12-31 | $2.60M 20-F · filed 2025-04-04 | |
| 2021-12-31 | $1.70M 20-F · filed 2024-03-28 | |
| 2020-12-31 | $828.00K 10-K · filed 2022-03-30 |